Bortezomib nanoparticle (Tharimmune)
硼替佐咪纳米粒 (Tharimmune)
Report date: 2024/01/26 15:35:59
Base Information
Drug NameBortezomib nanoparticle (Tharimmune)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTharimmune Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A